What Does PanTher Therapeutics Do?

Total employees17
HeadquartersCambridge
Founded2016

Panther Therapeutics is a Cambridge, MA-based biotechnology company focused on developing the next generation of targeted cancer therapies. Leveraging its proprietary Sagittari™ platform, Panther designs and develops tumor-restricted therapeutics, such as antibody-drug conjugates (ADCs) and STING agonists, that are engineered to be preferentially activated within the tumor microenvironment. This approach aims to maximize efficacy against cancer cells while minimizing systemic toxicity and improving the therapeutic window for potent anti-cancer agents. Their lead programs target challenging oncology indications with high unmet medical needs.

Where Is PanTher Therapeutics's Headquarters?

HQ Function

Core research and development activities, including discovery, preclinical studies, and formulation for its oncology pipeline. Also serves as the center for strategic planning, business development, and corporate operations.

Notable Features:

Operates within LabCentral, a premier shared laboratory and co-working space for life-science startups, offering access to advanced research equipment, operational support, and a vibrant entrepreneurial ecosystem.

Work Culture:

A fast-paced, innovative, and highly collaborative environment focused on scientific excellence and translating research into impactful cancer therapies. Emphasis on teamwork and entrepreneurial spirit within the supportive LabCentral community.

HQ Significance:

Its Cambridge location places Panther Therapeutics in the heart of one of the world's leading biotechnology clusters, providing unparalleled access to talent, academic collaborations, investors, and industry partners crucial for growth and innovation in oncology.

Values Reflected in HQ: The choice of LabCentral reflects Panther Therapeutics' commitment to efficiency, collaboration, cutting-edge science, and resourcefulness, allowing the company to prioritize its core mission of developing novel cancer treatments.

Location:

Panther Therapeutics is primarily based in the United States. While its direct physical presence is concentrated at its Cambridge headquarters, the company's mission to develop impactful cancer therapies has global implications. As its drug candidates progress, Panther Therapeutics may engage in international clinical trials, collaborations with global research institutions, and partnerships with pharmaceutical companies worldwide to bring its innovations to patients globally. Currently, specific international office locations are not publicly listed.

Street Address:

c/o LabCentral, 700 Main Street North

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does PanTher Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for PanTher Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading PanTher Therapeutics? Meet the Executive Team

As of April 2025, PanTher Therapeutics' leadership includes:

Teo Bombas, PhD - Co-Founder & Chief Executive Officer
Dustin Armstrong, PhD - VP, Head of Chemistry
Philippe Glinka, PhD - VP, Head of Biology

Who's Investing in PanTher Therapeutics?

PanTher Therapeutics has been backed by several prominent investors over the years, including:

Sofinnova Partners
Abingworth
Roche Venture Fund
Schmidt Futures
The Leukemia & Lymphoma Society’s Therapy Acceleration Program (LLS TAP)

What Leadership Changes Has PanTher Therapeutics Seen Recently?

Hire0
Exits0

Based on publicly available information, there have been no major C-suite or VP-level executive hires or departures announced by Panther Therapeutics in the last 12 months. The current leadership team appears focused on advancing the company's pipeline following its Series A financing.

What Technology (Tech Stack) Is Used byPanTher Therapeutics?

Discover the tools PanTher Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

PanTher Therapeutics Email Formats and Examples

Panther Therapeutics likely utilizes standard corporate email formats based on employee names and their company domain, panthertx.com. A common pattern for technology and biotech companies is the first initial followed by the last name.

[first_initial][last]@panthertx.com

Format

tbombas@panthertx.com

Example

70%

Success rate

What's the Latest News About PanTher Therapeutics?

Panther Therapeutics Website / Business Wire • April 5, 2024

Panther Therapeutics to Present Preclinical Data on PTM-001 and its Proprietary Sagittari™ Platform at the AACR Annual Meeting 2024

Panther Therapeutics announced its upcoming presentation of preclinical data for PTM-001, its STING agonist antibody-drug conjugate (ADC) product candidate, at the American Association for Cancer Research (AACR) Annual Meeting 2024. The presentation will also highlight the company's Sagittari™ targeted delivery platform....more

PR Newswire • May 2, 2023

Panther Therapeutics Launches With $52 Million Series A Financing to Advance a Pipeline of Tumor-Targeted Therapeutics

Panther Therapeutics officially launched with the announcement of a $52 million Series A financing. The funding was co-led by Sofinnova Partners and Abingworth, with significant participation from Roche Venture Fund, Schmidt Futures, and others. These funds are designated to advance Panther's pipeline of tumor-targeted therapeutics, developed using its proprietary Sagittari™ platform....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including PanTher Therapeutics, are just a search away.